APA (7th ed.) Citation

HC, C., N, M., K, S., C, K., E, R., CM, S., . . . M, d. l. R. (2024). Publisher Correction: Novel immunotherapeutics against LGR5 to target multiple cancer types. EMBO molecular medicine, 16(11), 3026. https://doi.org/10.1038/s44321-024-00139-6

Chicago Style (17th ed.) Citation

HC, Chen, et al. "Publisher Correction: Novel Immunotherapeutics Against LGR5 to Target Multiple Cancer Types." EMBO Molecular Medicine 16, no. 11 (2024): 3026. https://doi.org/10.1038/s44321-024-00139-6.

MLA (9th ed.) Citation

HC, Chen, et al. "Publisher Correction: Novel Immunotherapeutics Against LGR5 to Target Multiple Cancer Types." EMBO Molecular Medicine, vol. 16, no. 11, 2024, p. 3026, https://doi.org/10.1038/s44321-024-00139-6.